Off-label use of antipsychotic medications in Medicaid.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Managed Care

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 22435962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Assessment: Symptomatic treatment for muscle cramps (an evidence-based review)

  2010cited by this paper
• Dual eligibles with mental disorders and Medicare part D: how are they faring?

  2009cited by this paper
• Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making.

  2008cited by this paper
• Prioritizing Future Research on Off‐Label Prescribing: Results of a Quantitative Evaluation

  2008cited by this paper
• Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease.

  2007cited by this paper
• Rethinking antipsychotic formulary policy.

  2007cited by this paper
• Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001.

  2006cited by this paper
• Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

  2006cited by this paper
• Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

  2006cited by this paper
• Off-label prescribing among office-based physicians.

  2006cited by this paper
• Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach

  2006cited by this paper
• Mental health policy and psychotropic drugs.

  2005cited by this paper
• Do new prescription drugs pay for themselves? The case of second-generation antipsychotics.

  2005cited by this paper
• From Clinical Trials to Real-World Practice: Use of Atypical Antipsychotic Medication Nationally in the Department of Veterans Affairs

  2001cited by this paper
• Evaluation of the HEDIS measure of behavioral health care quality. Health Plan Employer Data and Information Set.

  1997cited by this paper

• Clinical practice guidelines for the treatment of tardive dyskinesia in Europe: A descriptive review

  2025cites this paper
• Diagnostic Patterns and Racial/Ethnic Differences in Antipsychotic Prescribing Among Privately Insured Youth.

  2025cites this paper
• Antipsychotic off-label use in the 21st century: An enduring public health concern

  2025cites this paper
• Association of Psychotropic Prescriptions With Non‐Registered Indications and the Risk of Mortality in Older Adults: A Danish Nationwide Cohort Study

  2024cites this paper
• Risk of Major Malformations Following First-Trimester Exposure to Olanzapine

  2023cites this paper
• The Protective Effect of Clozapine on Suicide: A Population Mortality Study of Statewide Autopsy Records in Maryland.

  2023cites this paper
• Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States

  2022cites this paper
• Antipsychotic prescription patterns and associated factors among the elderly with psychiatric illnesses

  2022cites this paper
• Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents

  2022cites this paper
• Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016

  2021cites this paper
• Off-label antipsychotic use patterns among Texas Medicaid adults 2013-2016.

  2021cites this paper
• Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured Adults.

  2021cites this paper
• Increased risk of falls and fractures in patients with psychosis and Parkinson disease

  2021cites this paper
• Real-world data on new users of atypical antipsychotics: characterisation, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database

  2020cites this paper
• Off-Label Use of Antipsychotics and Health Related Quality of Life in Community Living Older Adults

  2020cites this paper
• The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use

  2020cites this paper
• Stroke Risk Among Elderly Users of Haloperidol and Typical Antipsychotics Versus Atypical Antipsychotics: A Real-World Study From a US Health Insurance Claims Database.

  2020cites this paper
• Off-Label Use of Antipsychotics and Health Related Quality of Life in Community Living Older Adults

  2019influential citation
• Association Between Antipsychotics and All-Cause Mortality Among Community-Dwelling Older Adults.

  2019cites this paper
• Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis

  2019cites this paper
• Off-label use of antipsychotics and associated factors in community living older adults*

  2019influential citation
• Antipsychotics prescribing and ethnicity

  2018cites this paper
• Determinants of drug utilisation during childhood

  2018cites this paper
• Differences in Medicaid Antipsychotic Medication Measures Among Children with SSI, Foster Care, and Income-Based Aid

  2018cites this paper
• Patterns and predictors of off-label prescription of psychiatric drugs

  2018cites this paper
• Bennie, M. and Bishop, I. and Godman, B. and Barbui, C. and Raschi, E. and Campbell, S. and Miranda, J. and Gustafsson, L.L. (2013) Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?

  2018cites this paper
• Determining Associations with Word Embedding in Heterogeneous Network for Detecting Off-Label Drug Uses

  2017cites this paper
• Off-label use of psychotropic drugs beyond officially approved indications in Colombia Uso

  2017cites this paper
• The prescribing pattern of paliperidone in a pediatric population

  2017cites this paper
• Off-label use of psychotropic drugs beyond officially approved indications in Colombia

  2017cites this paper
• Automated Off-label Drug Use Detection from User Generated Content

  2017influential citation
• Racial/Ethnic Differences in Diagnoses and Treatment of Mental Health Conditions across Healthcare Systems Participating in the Mental Health Research Network

  2016cites this paper
• Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings

  2016cites this paper
• Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network.

  2016cites this paper
• Psychotropic medicine prescriptions in Italian youths: a multiregional study

  2016cites this paper
• Forecasting Medicaid Expenditures for Antipsychotic Medications.

  2015cites this paper
• Persistence of racial disparities in prescription of first‐generation antipsychotics in the USA

  2015cites this paper
• Use of Antipsychotics: A Study from the French National Insurance Healthcare System Database

  2015influential citation
• Antipsychotic treatment of adults in the United States.

  2015cites this paper
• Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.

  2015cites this paper
• A Prospective Cohort Study of Antipsychotic Medications in Pregnancy: The First 147 Pregnancies and 100 One Year Old Babies

  2014cites this paper
• Technology diffusion in the antipsychotic market : a comparison of France and the USA between 1998 and 2008

  2014cites this paper
• Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

  2014cites this paper
• Place des antipsychotiques de seconde génération dans le traitement au long cours des troubles bipolaires

  2014cites this paper
• Characteristics and trends of low‐dose quetiapine use in two western state Medicaid programs

  2014cites this paper
• Antipsychotic Medication and Risk of QTc Prolongation: Focus on Multiple Medication and Role of Cytochrome P450 Isoforms

  2014cites this paper
• Antipsychotic Prescriptions for Children Aged 5 Years or Younger

  2014influential citation
• Implications of off-label use: An example from the final results of an observational cohort study on Intrinsa® (testosterone patch)

  2014cites this paper
• Consumer Perspectives on the Informed Consent of Off-label Drug Use in South Korea

  2014cites this paper
• Adverse Clinical Events Among Medicare Beneficiaries Using Antipsychotic Drugs: Linking Health Insurance Benefits and Clinical Needs

  2013cites this paper
• UseofAdministrativeDatatoIdentify Off-LabelUseofSecond-Generation AntipsychoticsinaMedicaidPopulation

  2013cites this paper
• Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications

  2013cites this paper
• Metabolic Monitoring of Patients Prescribed Second-Generation Antipsychotics

  2013cites this paper
• Diffusion of antipsychotics in the US And French markets, 1998-2008.

  2013cites this paper
• Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications

  2013cites this paper
• Second generation antipsychotics: evolution of scientific knowledge or uncovering fraud

  2013cites this paper
• Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population.

  2013cites this paper
• Generic atypical antipsychotic drugs in Belgium: their influence and implications.

  2013cites this paper
• Prescribing of psychotropic medications to the elderly population of a Canadian province: a retrospective study using administrative databases

  2013cites this paper
• Potential to Enhance the Prescribing of Generic Drugs in Patients with Mental Health Problems in Austria; Implications for the Future

  2013cites this paper
• Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.

  2013cites this paper
• Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study

  2013cites this paper
• Do Low- and Middle-Income Countries Learn from the Experience of High-Income Countries?

  2013cites this paper
• Atypical antipsychotics and diabetic ketoacidosis: a review

  2013cites this paper
• Poster #13 RECEPTOR BINDING PROFILES OF ANTIPSYCHOTIC MEDICATIONS AND GLUCOSE DYSREGULATION: AN ACUTE ANIMAL MODEL

  2012cites this paper
• An update on lipid profile screening in second-generation antipsychotic users in the USA

  2012cites this paper
• Putting Pediatric Off Label Prescribing on the Map: A Study to Understand which Children, Medications and Physicians are Involved in Prescribing Drugs for Unapproved Uses

  2012cites this paper
• Past exposure to neuroleptic drugs and risk of Parkinson disease in an elderly cohort

  2012cites this paper
• Controversies in Psychiatry and DSM-5: The Relevance for Social Work (Occasional Essay)

  2012cites this paper